Next Article in Journal
Prevention of the Pro-Aggressive Effects of Ethanol-Intoxicated Mice by Schisandrin B
Previous Article in Journal
Very Low-Calorie Ketogenic Diet (VLCKD) as Pre-Operative First-Line Dietary Therapy in Patients with Obesity Who Are Candidates for Bariatric Surgery
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 15
Issue 8
10.3390/nu15081908
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Some Immune Parameters of Term Newborns at Birth Are Associated with the Concentration of Iron, Copper and Magnesium in Maternal Serum

by
Karolina Rak
1,*,
Marzena Styczyńska
1,
Michaela Godyla-Jabłoński
1 and
Monika Bronkowska
2
1
Department of Human Nutrition, Faculty of Biotechnology and Food Science, Wroclaw University of Environmental and Life Sciences, 51-630 Wrocław, Poland
2
Institute of Health Sciences, Collegium Salutis Humanae, University of Opole, 45-060 Opole, Poland
*
Author to whom correspondence should be addressed.
Nutrients 2023, 15(8), 1908; https://doi.org/10.3390/nu15081908
Submission received: 3 March 2023 / Revised: 6 April 2023 / Accepted: 13 April 2023 / Published: 15 April 2023
(This article belongs to the Section Pediatric Nutrition)
Browse Figures
Versions Notes

Abstract

:
The nutritional status of pregnant women is considered to affect fetal development and the health condition of newborns, including their immune system. We investigated the relationship between the concentrations of magnesium (Mg), calcium (Ca), zinc (Zn), iron (Fe) and copper (Cu) in maternal serum (MS) and the concentrations of IgG antibodies and antineutrophil cytoplasmatic auto-antibodies against lactoferrin (Lf-ANCA) in umbilical cord serum (UCS). IgG was considered as a promoter of immunity, and Lf-ANCA as an inhibitor. The examined group consisted of 98 pregnant women and their healthy term newborn children. The concentrations of mineral elements were measured by FAAS/FAES, while the concentrations of antibodies were determined by ELISA. Excessive MS Fe and insufficient MS Cu were related to insufficient UCS IgG and excessive UCS Lf-ANCA. The correlation analysis showed confirming results. Adequate UCS IgG and Lf-ANCA were related to MS Mg at the strictly lower limit of the reference values. The results obtained seem to suggest that an excess of Fe and a deficiency of Cu in pregnancy may adversely affect some immune parameters of newborns. Reference values for MS Mg are likely to require reconsideration. It would be advisable to monitor the nutritional status of pregnant women with minerals in order to support the immune capacity of newborns.

1. Introduction

The immune system of newborns is functionally different (not immature as was thought until recently) compared to the adult counterpart, although the acquaintance with the functional capabilities of the immune system in the first period of extrauterine life remains limited [1]. The need to maintain the mutual immune tolerance between maternal and fetal organisms during pregnancy, as well as limited prenatal contact with antigens from the external environment, promotes the immunological calming of the fetus by inhibiting the development of immune memory and the maturation of specific immunity [2]. High concentrations of immunosuppressive compounds in the blood [3], initially only naïve T and B cells (without immune memory), as well as decreased sensitivity and reactivity of immune cells to foreign antigens [4], are characteristic for newborns.
The immunity of newborns at birth is based on two pillars—specific IgG antibodies downloaded from mothers by placental transport, and elements of their own non-specific immunity [2,5].
IgG antibodies are the main class of immunoglobulins involved in the fight against pathogenic microorganisms, and they participate in the secondary immune response [6,7]. Although the immune systems of newborns produce small amounts of IgM and IgA antibodies, they are unable to produce IgG antibodies—a key element of a highly precise specific immune response [3,4]. Maternal IgG antibodies are the only ones of the five classes of immunoglobulins capable of crossing the blood–placenta barrier and entering the fetal circulatory system [7], becoming the only source of neonatal specific immunity. Additionally, they are subject to active transport, and their intensity peak is observed in the last 4 weeks of prenatal life, i.e., after the 36th week of pregnancy [5,6,8,9]. Due to the above, maternal IgG antibodies were considered in our study as a promoter of the immunity of newborns.
Elements of the non-specific immunity of newborns, despite their functional difference and decreased reactivity, nevertheless constitute the first line of defense against pathogens. A key role is played by neutrophils—the dominant population of immune cells in newborns—which, after activation, are able to release various antimicrobial proteins from their granules, including lactoferrin with an unusually broad spectrum of killing and static activity against microorganisms and various immunomodulatory properties [10,11,12,13]. Considering the crucial role of lactoferrin in the organism’s defense against infections, as well as its importance in regulating the immune response, the presence of anti-lactoferrin antibodies (Lf-ANCA) in the blood should be considered highly detrimental. These antibodies belong to the antineutrophil cytoplasmatic auto-antibodies (ANCA)—a group of auto-antibodies against antigens contained in the cytoplasm of neutrophils—and impair the proper functioning of the immune system. Although the cause of the production of Lf-ANCA in the body has not been established so far, it is known that they underline many inflammatory and autoimmune diseases [14,15,16]. Moreover, lactoferrin deficiency has been demonstrated to be associated with recurrent infections [17,18], and the administration of lactoferrin may reduce the risk of infections of various origins [19,20,21]. Due to the above, Lf-ANCA auto-antibodies were considered in our study as an inhibitor of the immunity of newborns.
In prenatal life, many factors may affect fetal development and the health condition of newborns at birth. It has been demonstrated that one of the key determinants is the nutritional status of pregnant women. An inadequacy (insufficiency, excess or imbalance of nutrients) can lead to fetal programming resulting in adverse short- and long-term health consequences in offspring, including consequences related to immunity [22,23,24,25,26,27,28,29,30,31]. Improper nutritional status in pregnant women has been recognized to be a global problem in both low- and middLe-income and high-income countries [32,33,34,35]. Its cause may be not only an insufficient supply of nutrients with increased demand [36], but also their unbalanced supply (e.g., an excess of fats and simple sugars at the expense of other nutrients) [33,37,38] and an excessive use of supplementation (especially of vitamins and minerals) [39,40].
Although there are some published results suggesting that both an excess and an insufficiency of macro- and microelements during pregnancy may lead to detrimental effects for fetal development, maternal health conditions and the health of newborn children [36,41], according to our best knowledge there are no papers that have investigated the relationship between the mineral nutritional status of pregnant women and the immune parameters of newborns at birth.
Therefore, the aim of this study was to examine the relationship between the concentration of macro- and microelements (Mg, Ca, Zn, Fe, Cu) in the blood of pregnant women and the concentration of IgG antibodies (as a promoter of immunity) and Lf-ANCA auto-antibodies (as an inhibitor of immunity) in the umbilical cord blood serum of newborns. We hypothesized that an excessive or insufficient concentration of macro- and microelements in maternal blood may negatively affect some immune parameters of their offspring at birth.

2. Materials and Methods

2.1. Patients

Ninety-eight pregnant women from the Obstetrics and Gynecology Ward of the Provincial Specialist Hospital in Wroclaw Research and Development Centre (Wroclaw, Poland) and their full-term healthy newborn children (46 boys and 52 girls) were included in the research in 2016 (April–December). Participants had uncomplicated pregnancies terminated with caesarean section (CS) due to various medical indications (i.e., tokophobia, previous CS, advanced eye defect), and all of them declared no tobacco or alcohol use throughout the pregnancy. Women with natural labors and multiple pregnancies were not included in the research. The maternal and neonatal characteristics are presented in Table 1.

2.2. Determination in Neonatal Cord Blood Serum of IgG Antibodies as a Promoter of Immunity

Umbilical cord blood samples were collected during CS. After clotting, blood samples were centrifuged at 2000× g rpm for 15 min. Serum samples (UCS) were removed and stored at −80 °C until analysis [42]. The concentration of IgG antibodies in the UCS was analyzed in duplicate using the ELISA method (Human IgG Total Ready-SET-Go! ELISA, eBioscience, Bender MedSystem GmbH, Vienna, Austria) according to the protocol recommended by the manufacturer and included in the operating instructions. An Epoch microplate spectrophotometer (BioTek Instruments, Santa Clara, CA, USA) was used to measure the absorption. Concentrations of IgG antibodies were given in mg/dL.
Based on the reference values for the concentration of IgG antibodies in the cord blood serum [43], the examined newborns were divided into two groups:
-
Adequate concentration of IgG in the UCS, when it was 636–1606 mg/dL (which indicated the correct IgG-related immune functions of newborns);
-
Insufficient concentration of IgG in the UCS, when it was <636 mg/dL (which indicated impaired IgG-related immune functions of newborns).

2.3. Determination in Neonatal Cord Blood Serum of Lf-ANCA Auto-Antibodies as an Inhibitor of Immunity

The procedure for obtaining and storing UCS samples was described in the previous paragraph. The concentration of Lf-ANCA auto-antibodies in the UCS was analyzed in duplicate using the ELISA method (Lactoferrin Ab ELISA, Demeditec Diagnostics GmbH, Kiel, Germany), according to the protocol recommended by the manufacturer and included in the operating instructions. An Epoch microplate spectrophotometer (BioTek Instruments, USA) was used to measure the absorption. Concentrations of Lf-ANCA auto-antibodies were given in U/mL.
Based on the cut-off point for the concentration of Lf-ANCA in the blood serum provided by the manufacturer in the ELISA test instructions, the examined newborns were divided into two groups:
-
Adequate concentration of Lf-ANCA in the UCS, when it was <10 U/mL (i.e., the concentration of Lf-ANCA was too low to impair the immune functions of newborns);
-
Excessive concentration of Lf-ANCA in the UCS, when it was ≥10 U/mL (i.e., the concentration of Lf-ANCA was high enough to impair the immune functions of newborns).

2.4. Determination in Maternal Serum of Selected Macro- and Microelements

Maternal blood samples were collected in the fasting state before planned CS (no labor). The procedure for obtaining and storing MS samples was the same as for the UCS. The method of determining the concentration of macro- (Ca, Mg) and microelements (Zn, Fe, Cu) in the MS has been described in detail previously [44]. The concentrations of examined macro- and microelements in the MS were categorized based on reference values for women in the 3rd trimester of pregnancy (Table 2) [45].

2.5. Statistical Analysis

Statistical analysis was conducted with STATISTICA (10.0). The data analyzed in our study did not meet the conditions for the use of parametric tests due to the lack of normal distributions and heterogeneity of variance in the variables tested; therefore, non-parametric tests were used. In order to estimate the association between continuous variables, Spearman’s correlation was applied. The rank between two subgroups of independent variables was compared using the Mann–Whitney test, while the variance between three subgroups of independent variables was compared using the Kruskal–Wallis test. A p value ≤ 0.05 was considered statistically significant for all analyses [46]. The results were presented with the use of the size of examined subgroups (N), range (min–max), correlation coefficient (rho), median value (Me), interquartile range (IQR), quartiles (Q1–4), value of Mann–Whitney test (MW-Z) and value of Kruskal–Wallis test (KW-H).

2.6. Ethical Approval

The study design and procedure were approved by the Bioethics Committee at the Medical University of Wroclaw, Poland (KB-158/2016). Written informed consent was obtained from all examined women to participate in the study together with their newborn children.

3. Results

The median maternal age was 33, although the age range was much wider (19–45 years) and the median value of pBMI among pregnant women was 22.1. Examined newborns were born between the 37th and 41st weeks of pregnancy, with a median gestational age of 39 weeks and a median birth weight of 3430 g (IQR 3150–3730 g). Detailed data on maternal and neonatal characteristics are presented in Table 1, together with the descriptive statistics of the concentrations of macro- and microelements in the MS and the concentrations of antibodies in the UCS of newborns.
The results of the Spearman’s correlation between the concentrations of Mg, Ca, Zn, Fe and Cu in the MS and the concentrations of IgG antibodies and Lf-ANCA auto-antibodies in the UCS are presented in Table 3. The concentration of IgG antibodies in the UCS was negatively correlated with the concentration of Mg (rho = −0.354, p = 0.002) and Fe (rho = −0.368, p < 0.001) in the MS, and positively correlated with the concentration of Cu in the MS (rho = 0.361, p = 0.001). Simultaneously, the concentration of these mineral elements in the MS showed the opposite direction of correlation to the concentration of Lf-ANCA auto-antibodies (rho = 0.589, p < 0.001; rho = 0.635, p < 0.001; rho = −0.613, p < 0.001, respectively). Additionally, a statistically significant positive correlation was observed between the concentration of Ca and Zn in the MS and the concentration of Lf-ANCA auto-antibodies in the UCS. The statistically significant correlations demonstrated in Table 3 are graphically presented in Figure 1 and Figure 2.
The median values of the concentration of Mg, Ca, Zn, Fe and Cu in the MS in relation to the concentration of IgG antibodies and Lf-ANCA auto-antibodies in the UCS (insufficient, adequate and excessive) and the results of Mann–Whitney tests between subgroups are presented in Table 4. In mothers of newborns with an insufficient concentration of IgG antibodies in the UCS, significantly higher concentrations of Mg and Fe in the MS (for Fe, excessive) and a significantly lower (insufficient) concentration of Cu in the MS were observed compared to those of newborns with an adequate level of IgG antibodies. Similarly, higher concentrations of Mg and Fe in the MS (for Fe, excessive) and a lower concentration of Cu in the MS (insufficient) were observed in mothers of newborns with an excessive concentration of Lf-ANCA auto-antibodies in the UCS compared to those of newborns with an adequate level of Lf-ANCA auto-antibodies. Additionally, in mothers of newborns with an excessive concentration of Lf-ANCA auto-antibodies in the UCS, significantly higher concentrations of Ca and Zn in the MS were demonstrated compared to mothers of newborns with an adequate level of Lf-ANCA auto-antibodies.
The concentration of IgG antibodies and Lf-ANCA auto-antibodies in the UCS in relation to the concentration of selected mineral elements in the MS (insufficient, adequate and excessive) and the results of Mann–Whitney tests between subgroups are presented in Table 5 (UCS IgG) and Table 6 (UCS Lf-ANCA). A significantly higher concentration of IgG antibodies and a lower concentration of Lf-ANCA auto-antibodies were observed in the UCS of newborns born to mothers with an adequate concentration of Fe and Cu in the MS compared to those born to mothers with an excessive concentration of Fe and an insufficient concentration of Cu in the MS. Additionally, a significantly lower concentration of Lf-ANCA auto-antibodies in the UCS (specifically, the lack of them) was demonstrated in newborns of mothers with an insufficient concentration of Mg in the MS compared to those of mothers with an adequate level of this mineral element.
Due to a great proportion of an excessive concentration of Ca (98.8%) and an insufficient concentration of Zn (98.8%) in the examined group of women, the concentration of these mineral elements was divided into quartile subgroups, as a post hoc procedure. The concentrations of IgG antibodies and Lf-ANCA auto-antibodies in the UCS in relation to the concentrations of Ca and Zn in the MS (Q1, Q2, Q3, Q4) and the results of Kruskal–Wallis tests between subgroups are presented in Table 7 (UCS IgG) and Table 8 (UCS Lf-ANCA). No significant differences in the concentration of IgG antibodies in the UCS were observed in relation to the concentration of Ca and Zn in the MS. However, the lowest concentration of Lf-ANCA auto-antibodies in the UCS, equal to 0.00 U/mL, was shown in newborns of mothers with a concentration of Ca and Zn in the MS in the range of Q1 compared to those of mothers with a concentration of these mineral elements in Q2 (for Ca) and Q3 and Q4 (for Zn).

4. Discussion

4.1. Iron

In the course of our study, a relationship of excessive MS Fe with a reduced immune capacity resulting from decreased UCS IgG and increased UCS Lf-ANCA was observed. According to the best of our knowledge, there are no similar research results in the literature for comparison.
The literature is dominated by reports on iron deficiency and iron deficiency anemia (IDA). This is a global problem [47], especially common in pregnant women [48], and it has been shown to be associated with impaired immune functions [49].
The issue of over-saturation with iron is less known as the body has a very efficient mechanism for maintaining iron homeostasis [50] and its excess occurs only as a result of disease (e.g., hereditary haemochromatosis) or excessive supplementation. Iron-containing medical products are commonly used by pregnant women suffering from iron deficiency or IDA to optimize their iron nutritional status; however, prolonged treatment may lead to its excessive concentration in the body and adverse immune effects [51]. An increased concentration of iron in the blood has been demonstrated to inhibit the Th1 specific response, promote an inverted ratio of CD4+/CD8+ T cells and reduce the activity of NK cells [49].
The negative impact of over-saturation with iron on immune functions can be demonstrated by an increased susceptibility to infections in patients with hereditary haemochromatosis [52]. Similarly, the administration of iron-containing supplements to infants and children despite their adequate nutritional status regarding this mineral element enhances the risk and duration of infections [53,54,55,56]. A greater susceptibility to infections accompanying an over-saturation with iron may be associated with several mechanisms—the facilitated availability of iron for the development of pathogens [57], the increased production of reactive oxygen and nitrogen species resulting in oxidative stress [58], an impaired ability of macrophages to phagocytose as a result of their over-saturation with iron [52], the suppression of enzymes involved in immune mechanisms [59] and other changes in the functioning of the immune system [49].
The results obtained in our study seem to suggest that maternal over-saturation with iron may be a potential risk factor for neonatal infections; therefore, it would be advisable to monitor the concentration of iron in the blood of pregnant women, especially in those treated with iron-containing medical products due to iron deficiency or IDA, to limit potential adverse effects on immune functions.

4.2. Copper

As in the case of insufficient or excessive saturation with iron, an inadequate concentration of copper in the blood is associated with impaired immune functions [49,60]. People with copper levels near the lower reference limit have been shown to have reduced lymphocyte counts [49]. Additionally, the relationship of copper deficiency to neutropenia, the impaired functioning of neutrophils, limited antimicrobial activity and an increased susceptibility to infections has been demonstrated in animal models [60].
The results of our study seem to support these findings, as significantly lower UCS IgG and higher UCS Lf-ANCA were observed in newborns of mothers with an insufficient MS Cu compared to those born to mothers with an adequate level of this mineral element. According to the best of our knowledge, there are no reports in the literature on the relationship between maternal copper nutritional status and the immune functions or the risk of infections of the offspring. So far, only the effect of an insufficient copper concentration in the blood of pregnant women has been demonstrated on other health complications in mothers and fetuses, such as pre-eclampsia [61,62], gestational hypertension [63], congenital malformations of the fetus [64], intrauterine growth restriction (IUGR) [65] or premature birth [66], the causes of which are believed to be the oxidative stress resulting from the impaired activity of Cu-dependent antioxidant enzymes [67,68,69].

4.3. Magnesium

In our study, MS Mg in the examined pregnant women was negatively correlated with UCS IgG and positively correlated with UCS Lf-ANCA. Moreover, significantly higher UCS IgG and significantly lower Lf-ANCA were observed in newborns of mothers with an insufficient MS Mg compared to those born to mothers with an adequate nutritional status of this mineral element. It has also been found that MS Mg exceeding 1.15 mg/dL is related to a deficiency of UCS IgG and excess UCS Lf-ANCA. Our results therefore seem to suggest a potential adverse impact of magnesium, even in the range of reference values, on the immune capacity of newborns.
According to the best of our knowledge, there are no similar research results in the literature for comparison. It is known, however, that fetal exposure to magnesium sulphate (MgSO4)—commonly used in pregnant women in the prevention of pre-eclampsia, preterm labor and cerebral palsy [70]—may be associated with adverse consequences in newborns, the direct cause of which may be seen in an increased concentration of magnesium in both maternal and neonatal blood [71].
A significant correlation has been demonstrated for the dose of magnesium administered to pregnant women before labor and the concentration of magnesium in their blood with the concentration of this mineral element in the blood of newborns and the health effects observed in them [72]. Additionally, an increased frequency of hypotension [73,74,75], intraventricular hemorrhage (IVH) [76] and hospitalization in the neonatal intensive care unit (NICU) [77,78,79] has been observed in the newborns of mothers treated with MgSO4 in pregnancy. Interestingly, in a study on preterm neonates, adverse health effects were demonstrated in both groups of newborns with the highest (≥4.5 mg/dL) and lowest (<2.5 mg/dL) levels of magnesium in the blood; however, more serious effects were observed in the former (increased incidence of both IVH and periventricular leukomalacia (PVL)) compared to the latter (increased incidence of only IVH), while the neuroprotective effect of antenatal exposure to MgSO4 seemed to be related to the neonatal concentration of magnesium in the range 2.5–4.5 mg/dL [72]. It seems, therefore, that an excess of magnesium compared to its insufficiency may be more harmful to newborns. This is also confirmed by the results of studies on neonates with extremely low birth weight (ELBW) [80]. The concentration of magnesium in the blood at birth of newborns who died or showed neurological development disorders at the age of 9 months was significantly higher compared to those who survived and were characterized by normal neurological development (median [IQR]: 1.7 [1.55–2.1] vs. 1.5 [1.4–1.68] mg/dL).
The results of our study seem to be consistent with the literature cited above, related to the potentially adverse effects of magnesium on the health of newborns. Moreover, they suggest that reference values for MS Mg in pregnant women in the third trimester [46] are likely to require reconsideration towards lowering them; however, extensive research is needed on this issue.

4.4. Zinc

In our study, a positive correlation between MS Zn and UCS Lf-ANCA was observed and an adequate UCS Lf-ANCA was related to a profound maternal deficiency of zinc, while a milder maternal deficiency of zinc was associated with excessive UCS Lf-ANCA. Our results seem to suggest a potential adverse effect of zinc on the immune capacity of newborns that is inconsistent with the literature reports on the key role of zinc in immunity.
Zinc has been shown to have immunomodulatory properties and play a key role in maintaining normal immune functions, and its deficiency impairs the mechanisms of both innate and acquired immunity, including the production of antibodies, in particular IgG [81]. Additionally, it has been demonstrated in animal models that zinc deficiency during pregnancy results in a reduced concentration of IgM, IgA and IgG antibodies in the blood serum of the offspring, and this detrimental effect may persist (in an increasingly milder form) up to the third generation [82,83]. Similarly, an impaired cellular and humoral immune response to vaccination was observed in pups born to females fed with a low-zinc diet [84].
Reports on the impact of the zinc nutritional status of pregnant women on the immunity of their offspring are limited and concern mainly prenatal supplementation with this mineral element, not the saturation of the mother’s body. Zinc supplementation in pregnancy has been demonstrated to result in an increased concentration of IgG antibodies in neonates at birth [85], an increased immune response to vaccinations in infancy [86], a reduced risk of delayed hypersensitivity to a tuberculin test (PPD) [87] and a reduced risk of diarrhea [88,89,90], dysentery and impetigo [90] in infancy. The above results suggest the positive effect of prenatal exposure to zinc on shaping immune capacity, which contradicts our results. Inconsistency, however, could be caused by the very high proportion of zinc deficiency (96.9%) in the women examined in our study. Moreover, the cited literature concerned mothers and children from developing countries (Peru and Bangladesh), where there is a common problem of malnutrition with micro- and macronutrients; therefore, zinc supplementation in these women probably only optimized their nutritional status of this mineral element. Routine dietary supplementation with zinc in pregnancy is not recommended as its excess, like its deficiency, may adversely affect the immune functions of the offspring, as has been demonstrated in animal models [91,92].
Interestingly, in the examined study group, the coexistence of common zinc deficiency in mothers (96.9%) with a common deficiency of IgG antibodies in their newborn children (83.1%) was observed. These findings seem to confirm that zinc may be essential for the placental transport of antibodies, and its perinatal deficiency may limit the acquisition of maternal antibodies by the fetus and impair the development of immunity in early life [93].

4.5. Calcium

In our study, a positive correlation between MS Ca and UCS Lf-ANCA was demonstrated. However, a slight deterioration of the examined immune parameters of newborns was observed after exceeding MS Ca of 16 mg/dL (>Q1), although a significant increase in UCS Lf-ANCA was observed only in newborns whose mothers were characterized by MS Ca in the range of Q2 compared to Q1.
According to the best of our knowledge, there are no similar research results in the literature for comparison and there is little known about the impact of the calcium nutritional status of pregnant women on the immune capabilities of their offspring. It has only been shown that prenatal exposure to maternal calcium deficiency (and anemia) does not affect the immune response in infants [94]. On the other hand, a reduced risk of death in the neonatal period has been demonstrated in newborns whose mothers were supplied daily with at least 741 mg of calcium (Q4) [95]. The authors suggested that this could be an effect of the reduced risk of premature birth. However, the reduced risk of death in these newborns might also be a result of a supportive effect of calcium on their immunity, as they were highly exposed to parasitic infections and malaria (Tanzania).

5. Conclusions

In conclusion, a significant relationship between the mineral element nutritional status in pregnant women and the immune parameters in their term newborn children has been demonstrated. An excessive concentration of Fe and an insufficient concentration of Cu in the blood serum of pregnant women in the third trimester seemed to impair the immune capacity of newborns, significantly decreasing the concentration of IgG antibodies (as a promoter of immunity) and increasing the concentration of Lf-ANCA auto-antibodies (as an inhibitor of immunity) in cord blood. Moreover, reference values for MS Mg in pregnant women in the third trimester are likely to require reconsideration towards lowering them, as MS Mg exceeding 1.15 mg/dL, although in the strictly lower limit of reference values, was related to a deficiency of UCS IgG and excess UCS Lf-ANCA. Our results concerning the relationship between the zinc and calcium nutritional status of pregnant women and the immunity of newborns are inconclusive.
The results of our study showed the need to develop strategies to optimize the mineral element nutritional status of pregnant women, as this is likely to improve the immune capacity of newborns and reduce the risk of neonatal infections and further adverse health effects in the offspring.
However, the presented results and conclusions should be confirmed in further studies. We would recommend conducting them on a larger study group of mother–newborn pairs, exceeding the minimum sample size, which would make the results scientifically credible and allow their generalization to the entire population of pregnant women and their newborn children. It could be also desirable to control the potential confounding factors that may affect the examined immune parameters of newborns, i.e., maternal age, BMI, immune health condition of mothers, maternal diet and use of an adjusted multivariate model. Future studies could also include a broader spectrum of immune parameters measured to assess the potential of neonatal immune defenses, e.g., the level and activity of NK cells, T cells or complement system. Additionally, besides the measurements of immunological markers such as the concentration of antibodies or immune-active compounds in the blood, the frequency (and severity) of neonatal infections could be registered in order to verify their correlation.
Further research is needed before these results can be implemented in nutritional recommendations for pregnant women aimed at improving the immune capacity of newborns. At this stage, our results should be considered as an important signpost for future investigations.

Author Contributions

Conceptualization, K.R. and M.B.; methodology, K.R., M.S., M.G.-J. and M.B.; formal analysis, K.R.; investigation, K.R.; data curation, K.R.; visualization, K.R.; supervision, M.B.; project administration, K.R.; writing—original draft, K.R.; writing—review and editing, K.R., M.S., M.G.-J. and M.B.; funding acquisition, K.R. and M.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Faculty of Biotechnology and Food Science, Wroclaw University of Environmental and Life Sciences [under Grant nr B030/0015/16] and Wroclaw Centre of Biotechnology, program: The Leading National Research Centre (KNOW) for years 2014–2018 [under Grant nr P/2016/4]. The APC is co-financed by Wroclaw University of Environmental and Life Sciences.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved on 24.03.2016 by the Bioethics Committee at the Medical University of Wroclaw, Poland (KB-158/2016).

Informed Consent Statement

Participating pregnant women signed informed consent for themselves and their newborn children prior to their inclusion in the study.

Data Availability Statement

Data are available on reasonable request from the corresponding author.

Acknowledgments

The authors wish to thank Wojciech Witkiewicz, Director of Provincial Specialist Hospital in Wroclaw, Research and Development Centre, and Janusz Malinowski, the head of the Obstetrics and Gynecology Ward, for their permission to carry out the research in the hospital and ward. Many thanks also to midwives Barbara Smolińska and Elżbieta Ciesielska for collecting maternal blood samples, and for their kindness.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Wood, H.; Acharjee, A.; Pearce, H.; Quraishi, M.N.; Powell, R.; Rossiter, A.; Beggs, A.; Ewer, A.; Moss, P.; Toldi, G. Breastfeeding promotes early neonatal regulatory T-cell expansion and immune tolerance of non-inherited maternal antigens. Allergy 2021, 76, 2447–2460. [Google Scholar] [CrossRef] [PubMed]
  2. Maggini, S.; Pierre, A.; Calder, P.C. Immune function and micronutrient requirements change over the life course. Nutrients 2018, 10, 1531. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Pettengill, M.A.; van Haren, S.D.; Levy, O. Soluble mediators regulating immunity in early life. Front. Immunol. 2014, 5, 457. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Simon, A.K.; Hollander, G.A.; McMichael, A. Evolution of the immune system in humans from infancy to old age. Proc. Biol. Sci. 2015, 282, 20143085. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Palmeira, P.; Quinello, C.; Silveira-Lessa, A.; Zago, C.A.; Carneiro-Sampaio, M. IgG placental transfer in healthy and pathological pregnancies. Clin. Dev. Immunol. 2012, 2012, 985646. [Google Scholar] [CrossRef] [PubMed]
  6. Fouda, G.G.; Martinez, D.R.; Swamy, G.K.; Permar, S.R. The impact of IgG transplacental transfer on early life immunity. ImmunoHorizons 2018, 2, 14–25. [Google Scholar] [CrossRef] [Green Version]
  7. Schroeder, H.W.; Cavacini, L. Structure and function of immunoglobulins. J. Allergy Clin. Immunol. 2010, 125, 41–52. [Google Scholar] [CrossRef] [Green Version]
  8. Silveira Lessa, A.L.; Krebs, V.L.; Brasil, T.B.; Pontes, G.N.; Carneiro-Sampaio, M.; Palmeira, P. Preterm and term neonates transplacentally acquire IgG antibodies specific to LPS from Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa. FEMS Immunol. Med. Microbiol. 2011, 62, 236–243. [Google Scholar] [CrossRef] [Green Version]
  9. van den Berg, J.P.; Westerbeek, E.A.; Berbers, G.A.; van Gageldonk, P.G.; van der Klis, F.R.; van Elburg, R.M. Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, Heamofhilus influenzae type b, and neisseria meningitides serogroup C is lower in preterm compared with term infants. Pediatr. Infect. Dis. J. 2010, 29, 801–805. [Google Scholar] [CrossRef]
  10. Tung, Y.T.; Chen, H.L.; Yen, C.C.; Lee, P.Y.; Tsai, H.C.; Lin, M.F.; Chen, C.M. Bovine lactoferrin inhibits lung cancer growth through suppression of both inflammation and expression of vascular endothelial growth factor. J. Diary Sci. 2013, 96, 2095–2106. [Google Scholar] [CrossRef] [Green Version]
  11. Legrand, D. Overview of lactoferrin as a natural immune modulator. J. Pediatr. 2016, 173, 10–15. [Google Scholar] [CrossRef] [Green Version]
  12. Kyriakidia, K.S.; Tsianosa, V.E.; Karvounisa, E.; Christodouloub, D.K.; Katsanosb, K.H.; Tsianos, E.V. Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: Bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of infl ammatory bowel and other diseases. Ann. Gastroenterol. 2016, 29, 258–267. [Google Scholar] [CrossRef]
  13. Rak, K.; Bronkowska, M. Immunologiczne znaczenie siary. Hygeia Public Health 2014, 49, 249–254. [Google Scholar]
  14. Shida, H.; Nakazawa, D.; Tateyama, Y.; Miyoshi, A.; Kusunoki, Y.; Hattanda, F.; Masuda, S.; Tomaru, U.; Kawakami, T.; Atsumi, T.; et al. The presence of anti-lactoferrin antibodies in a subgroup of eosinophilic granulomatosis with polyangiitis patients and their possible contribution to enhancement of neutrophil extracellular trap formation. Front. Immunol. 2016, 7, 636. [Google Scholar] [CrossRef] [Green Version]
  15. Tan, L.; Zhang, Y.; Peng, W.; Chen, J.; Li, H.; Ming, F. Detection of anti-lactoferrin antibodies and anti-myeloperoxidase antibodies in autoimmune hepatitis: A retrospective study. J. Immunoassay Immunochem. 2014, 35, 388–397. [Google Scholar] [CrossRef]
  16. Caccavo, D.; Rigon, A.; Picardi, A.; Galluzzo, S.; Vadacca, M.; Ferri, G.M.; Amoroso, A.; Afeltra, A. Anti-lactoferrin antibodies in systemic lupus erythematosus: Isotypes and clinical correlates. Clin. Rheumatol. 2005, 24, 381–387. [Google Scholar] [CrossRef]
  17. Boxer, L.A.; Coates, T.D.; Haak, R.A.; Wolach, J.B.; Hoffstein, S.; Baehner, R.L. Lactoferrin deficiency associated with altered granulocyte function. N. Engl. J. Med. 1982, 307, 404–410. [Google Scholar] [CrossRef] [PubMed]
  18. Hanson, L.A.; Andersson, B.; Carlsson, B.; Dahlgren, U.; Porras, O.; Söderström, T.; Svanborg Edén, C.; Mellander, L. Defence of mucous membranes by antibodies, receptor analogues and non-specific host factors. Infection 1985, 13 (Suppl. S2), 166–170. [Google Scholar] [CrossRef]
  19. Wakabayashi, H.; Oda, H.; Yamauchi, K.; Abe, F. Lactoferrin for prevention of common viral infections. J. Infect. Chemother. 2014, 20, 666–671. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Ali, A.S.; Hasan, S.S.; Kow, C.S.; Merchant, H.A. Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials. Clin. Nutr. ESPEN 2021, 45, 26–32. [Google Scholar] [CrossRef] [PubMed]
  21. Kell, D.B.; Heyden, E.L.; Pretorius, E. The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria. Front. Immunol. 2020, 11, 1221. [Google Scholar] [CrossRef] [PubMed]
  22. Rodríguez-Rodríguez, P.; Ramiro-Cortijo, D.; Reyes-Hernández, C.G.; López de Pablo, A.; González, M.C.; Arribas, S.M. Implication of oxidative stress in fetal programming of cardiovascular disease. Front. Physiol. 2018, 9, 602. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Perrone, S.; Tataranno, M.L.; Santacroce, A.; Bracciali, C.; Riccitelli, M.; Alagna, M.G.; Longini, M.; Belvisi, E.; Bazzini, F.; Buonocore, G. Fetal programming, maternal nutrition, and oxidative stress hypothesis. J. Pediatr. Biochem. 2016, 6, 96–102. [Google Scholar]
  24. Fernandez-Twinn, D.S.; Constância, M.; Ozanne, S.E. Intergenerational epigenetic inheritance in models of developmental programming of adult disease. Semin. Cell Dev. Biol. 2015, 43, 85–95. [Google Scholar] [CrossRef] [PubMed]
  25. Marques, A.H.; O’Connor, T.G.; Roth, C.; Susser, E.; Bjorke-Monsen, A.-L. The influence of maternal prenatal and early childhood nutrition and maternal prenatal stress on offspring immune system development and neurodevelopmental disorders. Front. Neurosci. 2013, 7, 120. [Google Scholar] [CrossRef] [Green Version]
  26. Jennewein, M.F.; Abu-Raya, B.; Jiang, Y.; Alter, G.; Marchant, A. Transfer of maternal immunity and programming of the newborn immune system. Semin. Immunopathol. 2017, 39, 605–613. [Google Scholar] [CrossRef]
  27. Macpherson, A.J.; de Agüero, M.G.; Ganal-Vonarburg, S.C. How nutrition and the maternal microbiota shape the neonatal immune system. Nat. Rev. Immunol. 2017, 17, 508–517. [Google Scholar] [CrossRef]
  28. Amarasekera, M.; Prescott, S.L.; Palmer, D.J. Nutrition in early life, immune-programming and allergies: The role of epigenetics. Asian Pac. J. Allergy Immunol. 2013, 31, 175–182. [Google Scholar]
  29. Palmer, A.C. Nutritionally mediated programming of the developing immune system. Adv. Nutr. 2011, 2, 377–395. [Google Scholar] [CrossRef] [Green Version]
  30. Jones, K.D.; Berkley, J.A.; Warner, J.O. Perinatal nutrition and immunity to infection. Pediatr. Allergy Immunol. 2010, 21, 564–576. [Google Scholar] [CrossRef] [Green Version]
  31. Prentice, S. They are what you eat: Can nutritional factors during gestation and early infancy modulate the neonatal immune response? Front. Immunol. 2017, 8, 1641. [Google Scholar] [CrossRef] [PubMed]
  32. Darnton-Hill, I.; Mkparu, U.C. Micronutrients in pregnancy in low- and middLe-income countries. Nutrients 2015, 7, 1744–1768. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Black, R.E.; Victora, C.G.; Walker, S.P.; Bhutta, Z.A.; Christian, P.; de Onis, M.; Ezzati, M.; Grantham-McGregor, S.; Katz, J.; Martorell, R.; et al. Maternal and child undernutrition and overweight in low-income and middLe-income countries. Lancet 2013, 2, 427–451. [Google Scholar] [CrossRef] [PubMed]
  34. Torheim, L.E.; Ferguson, E.L.; Penrose, K.; Arimond, M. Women in resource-poor settings are at risk of inadequate intakes of multiple micronutrients. J. Nutr. 2010, 140, 2051–2058. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Parisi, F.; Laoreti, A.; Cetin, I. Multiple micronutrient need in pregnancy in industrialized countries. Ann. Nutr. Metab. 2014, 65, 13–21. [Google Scholar] [CrossRef]
  36. Gernand, A.D.; Schulze, K.J.; Stewart, C.P.; West, K.P., Jr.; Christian, P. Micronutrient deficiencies in pregnancy worldwide: Health effects and prevention. Nat. Rev. Endocrinol. 2016, 12, 274–289. [Google Scholar] [CrossRef] [Green Version]
  37. Cordain, L.; Eaton, S.B.; Sebastian, A.; Mann, N.; Lindeberg, S.; Watkins, B.A.; O’Keefe, J.H.; Brand-Miller, J. Origins and evolution of the Western diet: Health implications for 21st century. Am. J. Clin. Nutr. 2005, 81, 341–354. [Google Scholar] [CrossRef] [Green Version]
  38. Scholing, J.M.; Olthof, M.R.; Jonker, F.A.M.; Vrijkotte, T.G.M. Association between pre-pregnancy weight status and maternal micronutrient status in early pregnancy. Public Health Nutr. 2018, 21, 2046–2055. [Google Scholar] [CrossRef] [Green Version]
  39. Livock, M.; Anderson, P.J.; Lewis, S.; Bowden, S.; Muggli, E.; Halliday, J. Maternal micronutrient consumption periconceptionally and during pregnancy: A prospective cohort study. Public Health Nutr. 2016, 20, 294–304. [Google Scholar] [CrossRef] [Green Version]
  40. Hatzopoulou, K.; Filis, V.; Grammatikopoulou, M.G.; Kotzamanidis, C.; Tsigga, M. Greek pregnant women demonstrate inadequate micronutrient intake despite supplement use. J. Diet. Suppl. 2014, 11, 155–165. [Google Scholar] [CrossRef]
  41. Khayat, S.; Fanaei, H.; Ghanbarzehi, A. Minerals in Pregnancy and Lactation: A Review Article. JCDR 2017, 11, QE01–QE05. [Google Scholar] [CrossRef] [PubMed]
  42. Tuck, M.K.; Chan, D.W.; Chia, D.; Godwin, A.K.; Grizzle, W.E.; Krueger, K.E.; Rom, W.; Sanda, M.; Sorbara, L.; Stass, S.; et al. Standard operating procedures for serum and plasma collection: Early detection research network consensus statement Standard operating procedure integration working group. J. Proteome Res. 2009, 8, 113–117. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Jolliff, C.R.; Cost, K.M.; Stivrins, P.C.; Grossman, P.P.; Nolte, C.R.; Franco, S.M.; Fijan, K.J.; Fletcher, L.L.; Shriner, H.C. Reference intervals for serum IgG, IgA, IgM, C3, and C4 as determined by rate nephelometry. Clin. Chem. 1982, 28, 126–128. [Google Scholar] [CrossRef] [PubMed]
  44. Rak, K.; Łoźna, K.; Styczyńska, M.; Bobak, Ł.; Bronkowska, M. Oxidative stress at birth is associated with the concentration of iron and copper in maternal serum. Nutrients 2021, 13, 1491. [Google Scholar] [CrossRef] [PubMed]
  45. Abbassi-Ghanavati, M.; Greer, L.G.; Cunningham, F.G. Pregnancy and laboratory studies: A reference table for clinicians. Obstet. Gynecol. 2009, 114, 1326–1331. [Google Scholar] [CrossRef]
  46. Stanisz, A. The Accessible Course of Statistics with Use the STATISTICA PL for Medicine Examples; Basic Statistics; StatSoft Polska: Kraków, Poland, 2006; Volume 1. [Google Scholar]
  47. Camaschella, C. Iron deficiency. Blood 2019, 133, 30–39. [Google Scholar] [CrossRef] [Green Version]
  48. Breymann, C. Iron deficiency anemia in pregnancy. Semin. Hematol. 2015, 52, 339–347. [Google Scholar] [CrossRef]
  49. Wintergerst, E.S.; Maggini, S.; Hornig, D.H. Contribution of selected vitamins and trace elements to immune function. Ann. Nutr. Metab. 2007, 51, 301–323. [Google Scholar] [CrossRef] [Green Version]
  50. Ganz, T.; Nemeth, E. Iron homeostasis in host defence and inflammation. Nat. Rev. Immunol. 2015, 15, 500–510. [Google Scholar] [CrossRef] [Green Version]
  51. Ward, R.J.; Crichton, R.R.; Taylor, D.L.; Della Corte, L.; Srai, S.K.; Dexter, D.T. Iron and the immune system. J. Neural Transm. 2011, 118, 315–328. [Google Scholar] [CrossRef]
  52. Khan, F.A.; Fisher, M.A.; Khakoo, R.A. Association of hemochromatosis with infectious diseases: Expanding spectrum. Int. J. Infect. Dis. 2007, 11, 482–487. [Google Scholar] [CrossRef] [Green Version]
  53. Dewey, K.G.; Domellof, M.; Cohen, R.J.; Landa Rivera, L.; Hernell, O.; Lonnerdal, B. Iron supplementation affects growth and morbidity of breast-fed infants: Results of a randomized trial in Sweden and Honduras. J. Nutr. 2002, 132, 3249–3255. [Google Scholar] [CrossRef] [Green Version]
  54. Soofi, S.; Cousens, S.; Iqbal, S.P.; Akhund, T.; Khan, J.; Ahmed, I.; Zaidi, A.K.; Bhutta, Z.A. Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: A cluster-randomised trial. Lancet 2013, 382, 29–40. [Google Scholar] [CrossRef]
  55. Sazawal, S.; Black, R.E.; Ramsan, M.; Chwaya, H.M.; Stoltzfus, R.J.; Dutta, A.; Dhingra, U.; Kabole, I.; Deb, S.; Othman, M.K.; et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: Community-based, randomised, placebo-controlled trial. Lancet 2006, 367, 133–143. [Google Scholar] [CrossRef]
  56. Pasricha, S.R.; Hayes, E.; Kalumba, K.; Biggs, B.A. Effect of daily iron supplementation on health in children aged 4–23 months: A systematic review and meta-analysis of randomised controlled trials. Lancet Glob. Health 2013, 1, 77–86. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Kortman, G.A.; Boleij, A.; Swinkels, D.W.; Tjalsma, H. Iron availability increases the pathogenic potential of Salmonella typhimurium and other enteric pathogens at the intestinal epithelial interface. PLoS ONE 2012, 7, 29968. [Google Scholar] [CrossRef] [PubMed]
  58. Zhuang, T.; Han, H.; Yang, Z. Iron, oxidative stress and gestational diabetes. Nutrients 2014, 6, 3968–3980. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Beard, J.L. Iron biology in immune function, muscle metabolism and neuronal functioning. J. Nutr. 2001, 131, 568–580. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Williams, D.M. Clinical syndromes of copper deficiency. In Nutritional Anemia. Scientific Principles, Clinical Practice, and Public Health; Means, R.T., Jr., Ed.; Cambridge University Press: Cambridge, UK, 2019; pp. 111–132. [Google Scholar]
  61. Al-Jameil, N.; Tabassum, H.; Al-Mayouf, H.; Aljohar, H.I.; Alenzi, N.D.; Hijazy, S.M.; Khan, F.A. Analysis of serum trace elementscopper, manganese and zinc in preeclamptic pregnant women by inductively coupled plasma optical emission spectrometry: A prospective case controlled study in Riyadh, Saudi Arabia. Int. J. Clin. Exp. Pathol. 2014, 7, 1900–1910. [Google Scholar]
  62. Sarwar, M.S.; Ahmed, S.; Ullah, M.S.; Kabir, H.; Rahman, G.K.; Hasnat, A.; Islam, M.S. Comparative study of serum zinc, copper, manganese, and iron in preeclamptic pregnant women. Biol. Trace Elem. Res. 2013, 154, 14–20. [Google Scholar] [CrossRef] [PubMed]
  63. Biswas, S.; Roy, A.; Biswas, S. Comparative study of copper, zinc, ferritin, calcium and magnesium levels in pregnancy induced hypertension and normotensive primigravida mothers. Int. J. Res. Med. Sci. 2016, 4, 1879–1883. [Google Scholar] [CrossRef]
  64. Buamah, P.K.; Russell, M.; Milford-Ward, A.; Taylor, P.; Roberts, D.F. Serum copper concentration significantly less in abnormal pregnancies. Clin. Chem. 1984, 30, 1676–1677. [Google Scholar] [CrossRef] [PubMed]
  65. Shen, P.J.; Gong, B.; Xu, F.Y.; Luo, Y. Four trace elements in pregnant women and their relationships with adverse pregnancy outcomes. Eur. Rev. Med. Pharmacol. Sci. 2015, 19, 4690–4697. [Google Scholar] [PubMed]
  66. Li, Z.; Liang, C.; Huang, K.; Yan, S.; Tao, R.; Sheng, J.; Pan, W.; Xia, X.; Tao, Y.; Xiang, H.; et al. Umbilical Serum Copper Status and Neonatal Birth Outcomes: A Prospective Cohort Study. Biol. Trace Elem. Res. 2018, 183, 200–208. [Google Scholar] [CrossRef]
  67. Uriu-Adams, J.Y.; Keen, C.L. Copper, oxidative stress, and human health. Mol. Asp. Med. 2005, 26, 268–298. [Google Scholar] [CrossRef] [PubMed]
  68. Uriu-Adams, J.Y.; Scherr, R.E.; Lanoue, L.; Keen, C.L. Influence of copper on early development: Prenatal and postnatal considerations. Biofactors 2010, 36, 136–152. [Google Scholar] [CrossRef] [PubMed]
  69. Hawk, S.N.; Lanoue, L.; Keen, C.L.; Kwik-Uribe, C.L.; Rucker, R.B.; Uriu-Adams, J.Y. Copper-deficient rat embryos are characterized by low superoxide dismutase activity and elevated superoxide anions. Biol. Reprod. 2003, 68, 896–903. [Google Scholar] [CrossRef] [Green Version]
  70. Pryde, P.G.; Mittendorf, R. Contemporary usage of obstetric magnesium sulfate: Indication, contradiction, and relevance of dose. Obstet. Gynecol. 2009, 114, 669–673. [Google Scholar] [CrossRef]
  71. Sherwin, C.M.; Balch, A.; Campbell, S.C.; Fredrickson, J.; Clark, E.A.; Varner, M.; Stockmann, C.; Korgenski, E.K.; Bonkowsky, J.L.; Spigarelli, M.G. Maternal magnesium sulphate exposure predicts neonatal magnesium blood concentrations. Basic Clin. Pharmacol. Toxicol. 2014, 114, 318–322. [Google Scholar] [CrossRef] [Green Version]
  72. Narasimhulu, D.; Brown, A.; Egbert, N.M.; Rojas, M.; Haberman, S.; Bhutada, A.; Minkoff, H.; Rastogi, S. Maternal magnesium therapy, neonatal serum magnesium concentration and immediate neonatal outcomes. J. Perinatol. 2017, 37, 1297–1303. [Google Scholar] [CrossRef]
  73. Ambadkar, A.; Prasad, M.; Chauhan, A.R. Neonatal effects of maternal magnesium sulphate in late preterm and term pregnancies. J. Obstet. Gynaecol. India 2019, 69, 25–30. [Google Scholar] [CrossRef]
  74. Das, M.; Chaudhuri, P.; Mondal, B.C.; Mitra, S.; Bandyopadhyay, D.; Pramanik, S. Assessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen. Indian J. Pharmacol. 2015, 47, 502–508. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Abbassi-Ghanavati, M.; Alexander, J.; McIntire, D.; Savani, R.C.; Leveno, K.J. Neonatal effects of magnesium sulfate given to the mother. Am. J. Perinatol. 2012, 29, 795–800. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Mittendorf, R.; Dambrosia, J.; Pryde, P.G.; Lee, K.S.; Gianopoulos, J.G.; Besinger, R.E.; Tomich, P.G. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am. J. Obstet. Gynecol. 2002, 186, 1111–1118. [Google Scholar] [CrossRef] [PubMed]
  77. Grisen, A.; Greenberg, M.B.; El-Sayed, Y.Y.; Lee, H.; Carvalho, B.; Lyell, D.J. Magnesium sulphate exposure and neonatal intensive care unit admission at term. J. Perinatol. 2015, 35, 181–185. [Google Scholar] [CrossRef]
  78. Greenberg, M.B.; Penn, A.A.; Thomas, L.J.; El-Sayed, Y.Y.; Caughey, A.B.; Lyell, D.J. Neonatal medical admission in a term and late-preterm cohort exposed to magnesium sulfate. Am. J. Obstet. Gynecol. 2011, 204, 515.e1–515.e7. [Google Scholar] [CrossRef]
  79. Greenberg, M.B.; Penn, A.A.; Whitaker, K.R.; Kogut, E.A.; El-Sayed, Y.Y.; Caughey, A.B.; Lyell, D.J. Effect of magnesium sulphate exposure in term neonates. J. Perinatol. 2013, 33, 188–193. [Google Scholar] [CrossRef] [Green Version]
  80. Kim, S.Y.; El-Dib, M.; Ahmad, T.; Aly, H. Baseline serum magnesium concentrations and neurodevelopmental outcomes of extremely low birth weight premature infants. Early Hum. 2013, 89, 239–242. [Google Scholar] [CrossRef]
  81. Bonaventura, P.; Benedetti, G.; Albarede, F.; Miossec, P. Zinc and its role in immunity and inflammation. Autoimmun. Rev. 2015, 14, 277–285. [Google Scholar] [CrossRef]
  82. Beach, R.S.; Gershwin, M.E.; Hurley, L.S. Gestational zinc deprivation in mice: Persistence of immunodeficiency for three generations. Science 1982, 218, 469–471. [Google Scholar] [CrossRef]
  83. Beach, R.S.; Gershwin, M.E.; Hurley, L.S. Persistent immunological consequences of gestation zinc deprivation. Am. J. Clin. Nutr. 1983, 38, 579–590. [Google Scholar] [CrossRef] [PubMed]
  84. Shi, L.; Zhang, L.; Li, C.; Hu, X.; Wang, X.; Huang, Q.; Zhou, G. Dietary zinc deficiency impairs humoral and cellular immune response to BCG and ESAT-6/CFP-10 vaccination in offspring and adult rats. Tuberculosis 2016, 97, 86–96. [Google Scholar] [CrossRef]
  85. Osendarp, S.J.; West, C.E.; Black, R.E.; Maternal Zinc Supplementation Study Group. The need for maternal zinc supplementation in developing countries: An unresolved issue. J. Nutr. 2003, 1333, 817–827. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Ahmad, S.M.; Hossain, M.B.; Monirujjaman, M.; Islam, S.; Huda, M.N.; Kabir, Y.; Raqib, R.; Lönnerdal, B.L. Maternal zinc supplementation improves hepatitis B antibody response in infants but decreases plasma zinc level. Eur. J. Nutr. 2016, 55, 1823–1829. [Google Scholar] [CrossRef] [PubMed]
  87. Osendarp, S.J.; Fuch, G.J.; van Raaij, J.M.A.; Mahmud, H.; Tofail, F.; Black, R.E.; Prabhakar, H.; Santosham, M. The effect of zinc supplementation during pregnancy on immune response to Hib and BCG vaccines in Bangladesh. J. Trop. Pediatr. 2006, 52, 316–323. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  88. Iannotti, L.L.; Zavaleta, N.; León, Z.; Huasquiche, C.; Shankar, A.H.; Caulfield, L.E. Maternal zinc supple-mentation reduces diarrheal morbidity in Peruvian infants. J. Pediatr. 2010, 156, 960–964. [Google Scholar] [CrossRef] [PubMed]
  89. Wieringa, F.T.; Dijkhuizen, M.A.; Muhilal; Meer, J.W. Maternal micronutrient supplementation with zinc and beta-carotene affects morbidity and immune function of infants during the first 6 months of life. Eur. J. Clin. Nutr. 2010, 64, 1072–1079. [Google Scholar] [CrossRef]
  90. Osendarp, S.J.; van Raaij, J.M.; Darmstadt, G.L.; Baqui, A.H.; Hautvast, J.G.; Fuchs, G.J. Zinc supplementation during pregnancy and effects on growth and morbidity in low birth weight infants: A randomized placebo controlled trial. Lancet 2001, 357, 1080–1085. [Google Scholar] [CrossRef]
  91. Sharkar, M.T.; Jou, M.Y.; Hossain, M.B.; Lönnerdal, B.L.; Stephensen, C.B.; Ragib, R. Prenatal zinc supplementation of zinc-adequate rats adversely affects immunity in offspring. J. Nutr. 2011, 141, 1559–1564. [Google Scholar] [CrossRef] [Green Version]
  92. Ragib, R.; Hossain, M.B.; Kelleher, S.L.; Stephensen, C.B.; Lönnerdal, B.L. Zinc supplementation of pregnant rats with adequate zinc nutriture suppresses immune functions in their offspring. J. Nutr. 2007, 137, 1037–1042. [Google Scholar] [CrossRef] [Green Version]
  93. Shankar, A.H.; Prasad, A.S. Zinc and immune functions: The biological basis of altered resistance to infection. Am. J. Clin. Nutr. 1998, 68, 447S–463S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Xiao, M.; Qiu, Q.; Pang, X.; Liang, X.; Li, L.; Cui, F.; Wang, F.; Zhang, G.; Li, H.; Wang, L.; et al. Immune response in infants after universal high-dose hepatitis B vaccination: A community-based study in Beijing, China. Vaccine 2015, 33, 5878–5883. [Google Scholar] [CrossRef] [PubMed]
  95. Mosha, D.; Liu, E.; Hertzmark, E.; Chan, G.; Sudfeld, C.; Masanja, H.; Fawzi, W. Dietary iron and calcium intakes during pregnancy are associated with lower risk of prematurity, stillbirth and neonatal mortality among women in Tanzania. Public Health Nutr. 2016, 20, 678–686. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Nutrients 15 01908 g001 550
Figure 1. The scatterplot of the concentrations of IgG antibodies in the cord blood serum (UCS IgG) of newborns in relation to the concentration of iron (MS Fe), copper (MS Cu) and magnesium (MS Mg) in maternal serum.
Figure 1. The scatterplot of the concentrations of IgG antibodies in the cord blood serum (UCS IgG) of newborns in relation to the concentration of iron (MS Fe), copper (MS Cu) and magnesium (MS Mg) in maternal serum.
Nutrients 15 01908 g001
Nutrients 15 01908 g002 550
Figure 2. The scatterplot of the concentrations of antineutrophil cytoplasmatic auto-antibodies against lactoferrin in the umbilical cord serum (UCS Lf-ANCA) of newborns in relation to the concentration of iron (MS Fe), copper (MS Cu), zinc (MS Zn) and magnesium (MS Mg) in maternal serum.
Figure 2. The scatterplot of the concentrations of antineutrophil cytoplasmatic auto-antibodies against lactoferrin in the umbilical cord serum (UCS Lf-ANCA) of newborns in relation to the concentration of iron (MS Fe), copper (MS Cu), zinc (MS Zn) and magnesium (MS Mg) in maternal serum.
Nutrients 15 01908 g002
Table
Table 1. Maternal and neonatal characteristics (N = 98).
Table 1. Maternal and neonatal characteristics (N = 98).
NMeIQRMin–Max
Maternal characteristics
 Mother’s age [years]98 133.030.0–35.019.0–45.0
 Pre-pregnancy BMI [kg/m2]9822.120.1–25.118.0–32.9
 MS Mg [mg/dL] 2981.221.13–1.330.99–1.66
 MS Ca [mg/dL]9817.6815.93–18.9610.18–26.94
 MS Zn [µg/dL]9818.301.00–32.100.001–56.30
 MS Fe [µg/dL]98331.0167.0–555.00.001–1603.0
 MS Cu [µg/dL]9875.8538.00–122.50.000–248.10
Neonatal characteristics
 Gestational age [weeks]9839.038.0–39.037.0–41.0
 Birth weight [g]983430.03150.0–3730.02510.0–4980.00
 UCS IgG [mg/dL]77 2480.0370.0–568.078.0–1477.0
 UCS Lf-ANCA [U/mL]9817.700.001–47.800.001–163.10
MS—maternal serum, UCS—umbilical cord serum, IgG—IgG antibodies, Lf-ANCA—ANCA auto-antibodies against lactoferrin, Mg—magnesium, Ca—calcium, Zn—zinc, Fe—iron, Cu—copper, SD—standard deviation, Me—median, IQR—interquartile range. 1 N = 98—female newborns (♀ N = 52), male newborns (♂ N = 46). 2 N = 77 due to lack of data on the concentration of IgG antibodies in 21 samples of cord blood serum (11 female samples, 10 male samples); however, there were no statistically significant differences in any of the maternal or neonatal characteristics parameters between the study groups of N = 98 and N = 77 (p > 0.05), and sex proportions were preserved.
Table
Table 2. Reference values of the concentration of examined macro- and microelements in blood serum for women in the 3rd trimester of pregnancy [45].
Table 2. Reference values of the concentration of examined macro- and microelements in blood serum for women in the 3rd trimester of pregnancy [45].
Examined Elements
in the MS		InsufficientAdequateExcessive
Mg [mg/dL]<1.11.1–2.2>2.2
Ca [mg/dL]<8.28.2–9.7>9.7
Zn [µg/dL]<5050–77>77
Fe [µg/dL]<3030–193>193
Cu [µg/dL]<130130–240>240
MS—maternal serum, Mg—magnesium, Ca—calcium, Zn—zinc, Fe—iron, Cu—copper.
Table
Table 3. Spearman’s correlation between the concentration of macro- and microelements in the MS and the concentration of IgG antibodies and Lf-ANCA auto-antibodies in the UCS of newborns.
Table 3. Spearman’s correlation between the concentration of macro- and microelements in the MS and the concentration of IgG antibodies and Lf-ANCA auto-antibodies in the UCS of newborns.
Examined Elements
in the MS		UCS IgG [mg/dL]
(N = 77)		UCS Lf-ANCA [U/mL]
(N = 98)
RhopRhop
Mg [mg/dL]−0.3540.002 *0.589<0.001 *
Ca [mg/dL]0.0600.6060.2140.034 *
Zn [ug/dL]−0.1980.0840.358<0.001 *
Fe [ug/dL]−0.368<0.001 *0.635<0.001 *
Cu [ug/dL]0.3610.001 *−0.613<0.001 *
MS—maternal blood serum, UCS—umbilical cord blood serum, IgG—IgG antibodies, Lf-ANCA—ANCA auto-antibodies against lactoferrin, Mg—magnesium, Ca—calcium, Zn—zinc, Fe—iron, Cu—copper, rho—correlation coefficient. * statistical significance p ≤ 0.05.
Table
Table 4. Median values of the concentration of macro- and microelements in the MS in relation to the concentration of IgG antibodies and Lf-ANCA auto-antibodies in the UCS (insufficient, adequate and excessive).
Table 4. Median values of the concentration of macro- and microelements in the MS in relation to the concentration of IgG antibodies and Lf-ANCA auto-antibodies in the UCS (insufficient, adequate and excessive).
Examined
Elements
in the MS 3		UCS IgG [mg/dL] 1MW-ZpUCS Lf-ANCA [U/mL] 2MW-Zp
Adequate
(N = 13)		Insufficient
(N = 64)		Adequate
(N = 45)		Excessive
(N = 53)
Me (IQR)Me (IQR)Me (IQR)Me (IQR)
Mg [mg/dL]1.15
(1.09–1.17)		1.23
(1.15–1.33)		1.9920.046 *1.13
(1.08–1.19)		1.31
(1.22–1.36)		−6.195<0.001 *
Ca [mg/dL]16.58
(14.49–20.07)		17.57
(15.96–18.96)		0.3600.71916.73
(13.13–18.67)		17.88
(17.13–19.00)		−2.0320.042 *
Zn [ug/dL]10.50
(6.20–20.90)		17.65
(0.50–32.80)		1.5500.12110.20
(0.00–21.85)		24.60
(12.10–36.40)		−3.663<0.001 *
Fe [ug/dL]178.0
(117.0–253.0)		366.0
(174.5–564.0)		1.9920.046 *146.50
(84.50–270.00)		540.00
(427.0–596.0)		−6.549<0.000 *
Cu [ug/dL]134.90
(114.0–147.80)		71.05
(39.90–112.65)		−2.5840.010 *120.30
(97.80–145.10)		49.60
(11.40–73.70)		6.120<0.001 *
MS—maternal blood serum, UCS—umbilical cord blood serum, IgG—IgG antibodies, Lf-ANCA—ANCA auto-antibodies against lactoferrin, Mg—magnesium, Ca—calcium, Zn—zinc, Fe—iron, Cu—copper, Me—median, IQR—interquantile range, MW-Z—value of Mann–Whitney test. 1 UCS IgG—adequate: 636–1606 mg/dL, insufficient ≤ 636 mg/dL; 2 Lf-ANCA—adequate: <10 U/mL, excessive: ≥10 U/mL. 3 Reference values: Mg 1.1–2.2 mg/dL, Ca 8.2–9.7 mg/dL, Zn 50–77 μg/dL, Fe 30–193 μg/dL, Cu 130–240 μg/dL. * statistical significance p ≤ 0.05.
Table
Table 5. The concentration of IgG antibodies in the UCS in relation to the concentration of macro- and microelements in the MS (insufficient, adequate and excessive).
Table 5. The concentration of IgG antibodies in the UCS in relation to the concentration of macro- and microelements in the MS (insufficient, adequate and excessive).
Examined Elements in the MSUCS IgG [mg/dL]MW-Zp
Insufficient AdequateExcessive
NMeIQRNMeIQRNMeIQR
Mg [mg/dL]13507.00463.00–686.5064462.50313.00–559.500------−1.7660.077
Ca [mg/dL]0------0------77469.00351.00–564.00------
Zn [µg/dL]76468.50348.00–566.001------0------------
Fe [µg/dL]3------22509.00445.00–662.0052451.50289.00–557.502.2230.026 *
Cu [µg/dL]57450.00307.00–548.0020560.00499.50–681.500------−3.1660.002 *
MS—maternal blood serum, UCS—umbilical cord blood serum, IgG—IgG antibodies, Mg—magnesium, Ca—calcium, Zn—zinc, Fe—iron, Cu—copper, Me—median, IQR—interquantile range, MW-Z—value of Mann–Whitney test. * statistical significance p ≤ 0.05.
Table
Table 6. The concentration of Lf-ANCA auto-antibodies in the UCS in relation to the concentration of macro- and microelements in the MS (insufficient, adequate and excessive).
Table 6. The concentration of Lf-ANCA auto-antibodies in the UCS in relation to the concentration of macro- and microelements in the MS (insufficient, adequate and excessive).
Examined Elements
in the MS		UCS Lf-ANCA [U/mL]MW-Zp
Insufficient AdequateExcessive
NMeIQRNMeIQRNMeIQR
Mg [mg/dL]160.000.00–0.008230.700.00–55.500------−4.136<0.001 *
Ca [mg/dL]0------0------9818.750.00–47.80------
Zn [µg/dL]9521.450.00–48.903------0------------
Fe [µg/dL]2------290.000.00–4.306736.9512.70–64.40−5.007<0.001 *
Cu [µg/dL]7532.800.00–55.50220.000.00–7.951------3.687<0.001 *
MS—maternal blood serum, UCS—umbilical cord blood serum, Lf-ANCA—ANCA auto-antibodies against lactoferrin, Mg—magnesium, Ca—calcium, Zn—zinc, Fe—iron, Cu—copper, Me—median, IQR—interquantile range, MW-Z—value of Mann–Whitney test. * statistical significance p ≤ 0.05.
Table
Table 7. The concentration of IgG antibodies in the UCS in relation to the concentration of Ca and Zn in the MS divided into quartiles.
Table 7. The concentration of IgG antibodies in the UCS in relation to the concentration of Ca and Zn in the MS divided into quartiles.
Examined
Elements
in the MS		UCS IgG [mg/dL]KW-Hp *
Q1Q2Q3Q4
NMeIQRNMeIQRNMeIQRNMeIQR
Ca [mg/dL]20460.0345.0–576.019467.0272.0–548.019462.0292.0–549.019487.0413.0–597.03.2500.354
Zn [µg/dL]20461.5409.5–541.019547.0403.0–632.019505.0418.5–624.019356.0267.0–503.07.9460.047 1
MS—maternal blood serum, UCS—umbilical cord blood serum, IgG—IgG antibodies, Ca—calcium, Zn—zinc, Me—median, IQR—interquantile range, KW-H—value of Kruskal–Wallis test. * statistical significance p ≤ 0.05. 1 Tukey’s post hoc tests demonstrated no statistically significant differences in pairs of quartiles. For MS Ca (N = 77): Q1 ≤ 15.93; 15.93 < Q2 ≤ 17.55; 17.55 < Q3 ≤ 18.97; Q4 > 18.97 mg/dL. For MS Zn (N = 77): Q1 ≤ 1.0; 1.0 < Q2 ≤ 15.8; 15.8 < Q3 ≤ 31.1; Q4 > 31.1 µg/dL.
Table
Table 8. The concentration of Lf-ANCA auto-antibodies in the UCS in relation to the concentration of Ca and Zn in the MS divided into quartiles.
Table 8. The concentration of Lf-ANCA auto-antibodies in the UCS in relation to the concentration of Ca and Zn in the MS divided into quartiles.
Examined
Elements
in the MS		UCS Lf-ANCA [U/mL]KW-Hp
Q1Q2Q3Q4
NMeIQRNMeIQRNMeIQRNMeIQR
Ca [mg/dL]230.00 ∆0.00–23.702534.30 ∆9.00–55.502519.800.80–47.802524.800.00–40.6011.6280.009 *
Zn [µg/dL]250.00 †◊0.00–24.802422.034.18–51.102535.10 †3.25–55.502436.00 ◊19.8–51.7015.0340.002 *
MS—maternal blood serum, UCS—umbilical cord blood serum, Lf-ANCA—ANCA auto-antibodies against lactoferrin, Ca—calcium, Zn—zinc, Me—median, IQR—interquantile range, KW-H—value of Kruskal–Wallis test. * statistical significance p ≤ 0.05. For MS Ca (N = 98): Q1 ≤ 16.08; 16.08 < Q2 ≤ 18.89; 18.89 < Q3 ≤ 20.86; Q4 > 20.86 mg/dL; ∆ p = 0.009; For MS Zn (N = 98): Q1 ≤ 10.8; 10.8 < Q2 ≤ 28.0; 28.0 < Q3 ≤ 40.9; Q4 > 40.9 µg/dL; † p = 0.015; ◊ p = 0.003.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rak, K.; Styczyńska, M.; Godyla-Jabłoński, M.; Bronkowska, M. Some Immune Parameters of Term Newborns at Birth Are Associated with the Concentration of Iron, Copper and Magnesium in Maternal Serum. Nutrients 2023, 15, 1908. https://doi.org/10.3390/nu15081908

AMA Style

Rak K, Styczyńska M, Godyla-Jabłoński M, Bronkowska M. Some Immune Parameters of Term Newborns at Birth Are Associated with the Concentration of Iron, Copper and Magnesium in Maternal Serum. Nutrients. 2023; 15(8):1908. https://doi.org/10.3390/nu15081908

Chicago/Turabian Style

Rak, Karolina, Marzena Styczyńska, Michaela Godyla-Jabłoński, and Monika Bronkowska. 2023. "Some Immune Parameters of Term Newborns at Birth Are Associated with the Concentration of Iron, Copper and Magnesium in Maternal Serum" Nutrients 15, no. 8: 1908. https://doi.org/10.3390/nu15081908

APA Style

Rak, K., Styczyńska, M., Godyla-Jabłoński, M., & Bronkowska, M. (2023). Some Immune Parameters of Term Newborns at Birth Are Associated with the Concentration of Iron, Copper and Magnesium in Maternal Serum. Nutrients, 15(8), 1908. https://doi.org/10.3390/nu15081908

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop